Clinical Trials
4 trialsNCT06917313 2026-06-02
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Yale University
Phase 2 Recruiting
NCT06617455 2026-05-06
VEnT
University of Michigan Rogel Cancer Center
Phase 2 Terminated
NCT07568236 2026-05-05
A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)
Chinese University of Hong Kong
Phase 2 Not yet recruiting
NCT06440967 2026-04-06
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Astellas Pharma Inc
Phase 3 Active not recruiting